- Theofilas, Panos;
- Ehrenberg, Alexander J;
- Dunlop, Sara;
- Di Lorenzo Alho, Ana T;
- Nguy, Austin;
- Leite, Renata Elaine Paraizo;
- Rodriguez, Roberta Diehl;
- Mejia, Maria B;
- Suemoto, Claudia K;
- De Lucena Ferretti-Rebustini, Renata Eloah;
- Polichiso, Livia;
- Nascimento, Camila F;
- Seeley, William W;
- Nitrini, Ricardo;
- Pasqualucci, Carlos Augusto;
- Filho, Wilson Jacob;
- Rueb, Udo;
- Neuhaus, John;
- Heinsen, Helmut;
- Grinberg, Lea T
Introduction
Alzheimer's disease (AD) progression follows a specific spreading pattern, emphasizing the need to characterize those brain areas that degenerate first. The brainstem's locus coeruleus (LC) is the first area to develop neurofibrillary changes (neurofibrillary tangles [NFTs]).Methods
The methods include unbiased stereological analyses in human brainstems to estimate LC volume and neuronal population in controls and individuals across all AD stages.Results
As the Braak stage increases by 1 unit, the LC volume decreases by 8.4%. Neuronal loss started only midway through AD progression. Age-related changes spare the LC.Discussion
The long gap between NFT accumulation and neuronal loss suggests that a second trigger may be necessary to induce neuronal death in AD. Imaging studies should determine whether LC volumetry can replicate the stage-wise atrophy observed here and how these changes are specific to AD. LC volumetry may develop into a screening biomarker for selecting high-yield candidates to undergo expensive and less accessible positron emission tomography scans and to monitor AD progression from presymptomatic stages.